NYSE:INFU InfuSystem (INFU) Stock Price, News & Analysis $5.41 -0.39 (-6.72%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$5.44 +0.03 (+0.55%) As of 05/23/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock About InfuSystem Stock (NYSE:INFU) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get InfuSystem alerts:Sign Up Key Stats Today's Range$5.38▼$5.8150-Day Range$4.70▼$6.1552-Week Range$4.61▼$9.97Volume175,434 shsAverage Volume94,146 shsMarket Capitalization$113.70 millionP/E Ratio90.18Dividend YieldN/APrice Target$13.00Consensus RatingStrong Buy Company OverviewInfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.Read More… InfuSystem Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks48th Percentile Overall ScoreINFU MarketRank™: InfuSystem scored higher than 48% of companies evaluated by MarketBeat, and ranked 537th out of 918 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.0 / 5Analyst RatingStrong Buy Amount of Analyst CoverageInfuSystem has only been the subject of 2 research reports in the past 90 days.Read more about InfuSystem's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth106.67% Earnings GrowthEarnings for InfuSystem are expected to grow by 106.67% in the coming year, from $0.15 to $0.31 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InfuSystem is 90.18, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.52.Price to Earnings Ratio vs. SectorThe P/E ratio of InfuSystem is 90.18, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.98.Price to Book Value per Share RatioInfuSystem has a P/B Ratio of 2.19. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for INFU. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInfuSystem does not currently pay a dividend.Dividend GrowthInfuSystem does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for INFU. News and Social Media2.9 / 5News Sentiment1.22 News SentimentInfuSystem has a news sentiment score of 1.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.75 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for InfuSystem this week, compared to 1 article on an average week.MarketBeat FollowsOnly 1 people have added InfuSystem to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership4.2 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, InfuSystem insiders have bought more of their company's stock than they have sold. Specifically, they have bought $36,269.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders11.40% of the stock of InfuSystem is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions71.13% of the stock of InfuSystem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about InfuSystem's insider trading history. Receive INFU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter. Email Address INFU Stock News HeadlinesInsider Buying: InfuSystem Holdings, Inc. (NYSE:INFU) COO Buys 1,967 Shares of StockMay 20, 2025 | insidertrades.comBarry G. Steele Acquires 3,000 Shares of InfuSystem Holdings, Inc. (NYSE:INFU) StockMay 16, 2025 | insidertrades.comMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.May 25, 2025 | Brownstone Research (Ad)InfuSystem (NYSE:INFU) Rating Lowered to "Buy" at StockNews.comMay 17, 2025 | americanbankingnews.comInfuSystem Holdings, Inc. (INFU) Q1 2025 Earnings Call TranscriptMay 10, 2025 | seekingalpha.comEarnings call transcript: InfuSystem Q1 2025 sees stock surge despite EPS missMay 10, 2025 | uk.investing.comInfuSystem Holdings, Inc. (AMEX:INFU) Q1 2025 Earnings Call TranscriptMay 10, 2025 | insidermonkey.comInfuSystem Reports First Quarter 2025 Financial ResultsMay 8, 2025 | finance.yahoo.comSee More Headlines INFU Stock Analysis - Frequently Asked Questions How have INFU shares performed this year? InfuSystem's stock was trading at $8.45 at the start of the year. Since then, INFU shares have decreased by 36.0% and is now trading at $5.41. View the best growth stocks for 2025 here. How were InfuSystem's earnings last quarter? InfuSystem Holdings, Inc. (NYSE:INFU) issued its quarterly earnings data on Thursday, November, 7th. The company reported $0.08 EPS for the quarter, meeting analysts' consensus estimates of $0.08. The business had revenue of $35.32 million for the quarter, compared to analyst estimates of $35.50 million. InfuSystem had a trailing twelve-month return on equity of 2.78% and a net margin of 1.12%. Who are InfuSystem's major shareholders? InfuSystem's top institutional shareholders include AWM Investment Company Inc. (7.74%), Minerva Advisors LLC (4.33%), Meros Investment Management LP (2.93%) and Punch & Associates Investment Management Inc. (2.92%). Insiders that own company stock include Richard Dilorio, Carrie Lachance, Christopher R Sansone, Barry G Steele, Paul Andrew Gendron, R Rimmy Malhotra, Thomas Mark Ruiz, Addam Chupa, Ralph F Boyd Jr, Kevin Whitman, Kenneth D Eichenbaum and Gregg Owen Lehman. View institutional ownership trends. How do I buy shares of InfuSystem? Shares of INFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of InfuSystem own? Based on aggregate information from My MarketBeat watchlists, some other companies that InfuSystem investors own include Advanced Micro Devices (AMD), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), Home Depot (HD), JPMorgan Chase & Co. (JPM) and Netflix (NFLX). Company Calendar Last Earnings11/07/2024Today5/25/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNYSE:INFU Previous SymbolNYSE:INFU CIK1337013 Webwww.infusystem.com Phone(248) 291-1210Fax800-455-4338Employees410Year FoundedN/APrice Target and Rating Average Stock Price Target$13.00 High Stock Price Target$13.00 Low Stock Price Target$13.00 Potential Upside/Downside+140.3%Consensus RatingStrong Buy Rating Score (0-4)4.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$0.14 Trailing P/E Ratio90.18 Forward P/E Ratio36.07 P/E GrowthN/ANet Income$870,000.00 Net Margins1.12% Pretax Margin2.65% Return on Equity2.78% Return on Assets1.41% Debt Debt-to-Equity Ratio0.50 Current Ratio1.98 Quick Ratio1.59 Sales & Book Value Annual Sales$137.58 million Price / Sales0.83 Cash Flow$0.42 per share Price / Cash Flow12.79 Book Value$2.47 per share Price / Book2.19Miscellaneous Outstanding Shares21,016,000Free Float19,095,000Market Cap$113.70 million OptionableOptionable Beta1.73 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (NYSE:INFU) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InfuSystem Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InfuSystem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.